ctrl K

Watchlist Price Alert

Sigilon Therapeutics Inc. (SGTX)

NASDAQ: SGTX · Real-Time Price · USD

22.47

-0.59 (-2.56%)

At close: Aug 10, 2023, 8:00 PM

Sigilon Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	12.94M	9.6M	13.37M	14.15M	4.64M
Cost of Revenue	n/a	n/a	n/a	n/a	n/a
Gross Profit	12.94M	9.6M	13.37M	14.15M	4.64M
Operating Income	-43.67M	-75.64M	-52.64M	-44.12M	-23.07M
Interest Income	946K	258K	312K	1.06M	698K
Pretax Income	-43.56M	-77.31M	-54.61M	-43.92M	-22.77M
Net Income	-43.46M	-78.24M	-54.87M	-44.57M	-22.77M
Selling & General & Admin	18.98M	20.17M	12.53M	10.17M	6.67M
Research & Development	37.63M	65.07M	53.49M	48.11M	21.04M
Other Expenses	1.45M	55K	-89K	-6K	-81K
Operating Expenses	56.61M	85.23M	66.02M	58.28M	27.71M
Interest Expense	2.29M	1.99M	1.2M	650K	289K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	56.61M	85.23M	66.02M	58.28M	27.71M
Income Tax Expense	-105K	925K	259K	644K	599K
Shares Outstanding (Basic)	32.41M	2.45M	2.42M	1.62M	1.21M
Shares Outstanding (Diluted)	32.41M	2.45M	2.42M	1.62M	1.21M
EPS (Basic)	-1.34	-31.92	-22.67	-27.53	-18.85
EPS (Diluted)	-1.34	-31.92	-22.67	-27.53	-18.85
EBITDA	-41.27M	-75.32M	-52.42M	-42.4M	-22.08M
EBIT	-41.27M	-75.32M	-53.41M	-43.27M	-22.89M
Depreciation & Amortization	2.4M	313K	223K	1.73M	374K